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Background: There have been lots of discussion and controversy concerning the difference between 
Low Carbohydrate Diet (LCD) and Calorie Restriction (CR). The important points include glucose 
variability, glucose-lowering effect, weight reduction degree and influence on lipid metabolism.  
 
Subjects and Methods: Enrolled subjects were 47 patients with T2DM. Methods included the study 
for providing subjects CR meal with 60% carbohydrate on day 1-2 and LCD meal with 12% on day 3-
14. Daily profile of blood glucose was studied seven times a day on day 2 and day 4. Further, 
biomarkers including HbA1c, average blood glucose, and M value were investigated and analyzed for 
mutual correlations. 
 
Results: Subjects were categorized into 4 groups according to the average glucose value, which 
were 124mg/dL, 160mg/dL, 206mg/dL, and 281mg/dL, respectively. Data in 4 groups were as follows: 
Number; 12,12,12,11, Male/Female; 6/6, 3/9, 6/6, 5/6, mean age; 51.3, 60.9, 65.3, 60.6 years old, 
HbA1c; 6.1%, 7.1%, 8.0%, 8.9%, fasting glucose on day 2; 109 mg/dL, 136 mg/dL, 178 mg/dL, 
224mg/dL, respectively. Daily profiles of blood glucose in 4 groups on day 4 were remarkably 
decreased than those of day 2. The levels of M value indicating average blood glucose and mean 
amplitude of glycemic excursions (MAGE) on day 2 vs 4 were compared in 4 groups, which are 7.1 vs 
10.5, 39.7 vs 5.0, 139 vs 15.7, 367 vs88, respectively. Correlations among HbA1c, M value and 
average blood glucose showed significant correlations (p<0.01). 
 
Discussion and Conclusion: Obtained results showed that the distribution of daily profile of blood 
glucose in 4 groups is separated. Further similar tendency was observed in HbA1c and M value. 
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There was remarkable decrease of blood glucose from CR to LCD. These findings suggested that 
LCD would have remarkable efficacy for improving glucose variability. Furthermore, obtained findings 
could become basal and reference data for the developing research for CR and LCD. 
 
Introduction 
Diabetes has been increasing, and about 451 
million people with diabetes are estimated to be 
present worldwide in 2017 [1]. The number will 
be expected to increase to 693 million by 2045. 
Among the people who are estimated to have 
diabetes at present, almost half of people with 
diabetes are not diagnosed yet. Thus, it is 
crucial to deal with diabetes medically and 
socially [2]. 
 
With regard to the diagnosis and treatment 
for diabetes, there have been controversies in 
several diabetes societies [3,4]. There have 
been some discussions about the 
recommended level of HbA1c that would be the 
goal for clinical management for diabetes, 
between the American Diabetes Association 
(ADA) and the American College of 
Physicians (ACP) in recent years [4,5]. From 
the clinical point of view, there have been 
diabetic variability with various heterogeneity. 
Then, we have to argue the adequate control 
situation in each diabetic patient [5,6].  
 
    The basal treatment for diabetes has been 
nutritional therapy. The basal treatment for 
diabetes has been diet therapy, which is one of 
the three main treatment for diabetes including 
i) diet therapy, ii) exercise therapy, iii) anti-
diabetic agents or insulin for medicine. As to the 
diet therapy for diabetes, there have been 
discussions about Calorie Restriction (CR) 
and Low Carbohydrate Diet (LCD) which are 
categorized into two major nutritional 
characteristics nutrition’s. Bernstein et al. has 
begun to present LCD in 1990’ and applied LCD 
for the treatment of diabetes [7].  
 
In succession, the report from the Dietary 
Intervention Randomized Controlled Trial 
(DIRECT) Group has been known widely [8]. 
They compared LCD, CR (Low-Fat Diet) and the 
Mediterranean diet, with the result of the 
predominance of LCD for 2 years. After that, the 
efficacy of LCD for 4 years of interventions was 
reported [9].  
 
    In contrast, authors and co-researchers have 
initiated LCD in Japan [10]. After that, we have 
developed the clinical efficacy of LCD through 
educational books and workshop for long [11]. 
Recently, Japan LCD promotion association has 
been established and its activities have continued 
[12]. We have also continued clinical research of 
LCD and CR and reported the significance and 
pathophysiological role of Ketone Bodies (KB) 
in the circumstances of the axis of fetus-placenta-
newborn-mother [13]. For patients with diabetes 
and Met-S and general people, we have 
presented three types of recommending LCD 
meals, such as super LCD, moderate LCD and 
petite LCD meals [14]. 
 
In this study, authors and colleagues have 
presented the comparison with CR meal and 
LCD meals for diabetic patients. Further, diabetic 
biomarkers including HbA1c, M value, lipids were 
investigated for mutual correlations for clarifying 
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Subjects and Methods 
   In this study, the enrolled subjects were 47 
patients, who were recently diagnosed as Type 
2 Diabetes Mellitus (T2DM). They were 
admitted to the hospital for further evaluation 
and treatment of diabetes. Especially, the 
purpose of the educational admission method is 
to understand two types of meal. During staying 
in the hospital, they have an experience of 
taking calorie restriction (CR) and also low 
carbohydrate diet (LCD), consecutively. For this 
series of nutritional education, they understand 
what are CR and LCD like, and have the 
fundamental knowledge and practice for 
diabetes mellitus. 
 
As to the detail of the methods, our research 
group has made our common diabetic formula 
protocol. It includes the diagnosis, examination, 
and treatment of the diabetic research program. 
The principle and the detail are as follows: 
 
   i) Concerning the diagnosis, the subjects in 
this study were diagnosed as T2DM in the 
recent period. We excluded specific types of 
diabetes, including type 1 diabetes mellitus 
(T1DM) or others. These patients with T2DM 
were not administered medicine for diabetes, 
which can influence glucose variability in daily 
profile and also postprandial glucose response. 
 
ii) The protocol included 14 days of further 
evaluation and treatment for T2DM. They were 
admitted in the hospital and were given several 
examinations. On the next day of the admission, 
which is day 2, they were drawn blood samples 
for fundamental examination after overnight 
fasting. The exams included complete blood 
count, renal and liver function test, lipids, and 
etc. Regarding examination items for diabetes, 
we ordered blood glucose level on fasting and 
postprandial time, as well as Immunoreactivity 
of Insulin (IRI), HbA1c, C-peptide, HOMA-R, 
HOMA-β, M value were obtained for the study. 
 
   iii) In our protocol, nutritional therapy includes 
two kinds of diet. CR meal was provided in day 
1 and 2 which has 1400 kcal/day with the PFC 
ratio as 15: 25: 60. This has been the standard 
Japanese meal pattern recommended by the 
Japan Diabetes Association (JDA) [15]. 
 
    iv) Successively, LCD meal was provided 
during day 3 to day 14. It has a 1400kcal/day 
with the PFC ratio from day 3 to 14 with super 
LCD. The content has 12% of carbohydrate with 
1400 kcal/day with 12% of carbohydrate ratio. 
This has been called as super-LCD, which has 
been well-known and popular in Japan. In our 
protocol, there are three types of LCD meals, 
which are super LCD, standard LCD with 26% of 
carbohydrate and petite LCD with 40% of 
carbohydrate. 
 
     v) Research protocol included the comparison 
of the values in several biomarkers  between  
day 2 and day 4, and between day 2 and day 14. 
The former included the comparison of CR and 
LCD meals on day 2 and day 4. The latter 
included the comparison of lipids such as 




    In order to clarify the daily profile of blood 
glucose, we measured blood glucose 7 times 
from morning until night. The times were 0800, 
1000, 1200, 1400, 1700, 1900 and 2200h. CR 
meal was given on day 1 and day 2, and a daily 
profile of blood glucose was studied on day 2. 
Similarly, LCD meal was given during day 3 and 
14, and a daily profile of blood glucose was 
studied on day 4. Glucose variability was 
investigated between day 2 and day 4. 
According to the obtained data of blood glucose 
7 times a day, blood glucose in average and M 
value were calculated by the calculation 
equation of the formula on M value [16, 17]. 
 
M value: 
    It is M value that has been evaluated as one 
of the useful biomarkers for glucose variability. M 
value shows two valuable meaningful data. The 
former means the value of the average blood 
glucose per day, and the latter means the width 
of the glucose fluctuation, which reveals the 
Mean Amplitude of Glycemic Excursions 
(MAGE) [18-20]. Both data obtained can 
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speculate the general glucose variability in a day. 
 
    Thus, M value can be revealed as a numerical 
value which includes two valuable markers. One 
is the degree of elevated blood glucose in 
average, and another is the increased swinging 
of the variability of blood glucose. By applying the 
mathematics method, we can calculate M value 
as the equation of the logarithmic transformation. 
As to the significance of M value, it means the 
degree of the glucose deviation from the ideal 
blood glucose profile in a day [19-21]. 
 
The calculation way for the M value includes 
three processes. The first one shows the basal 




. M value means 




. The second 
shows the M
W
, that expresses (maximum blood 
glucose − minimum glucose)/20. The last one 
revealed that M
BS
 is the mean of MBSBS. 
Summarizing these into one equation, MBSBS 
has been the individual M-value for each blood 
glucose, which is calculated as (absolute value of 




    Generally, there has been clinically estimation 
of judgment for glucose variability from the 
elevated level of M value. For the result of M 
value, the standard normal range has been less 
than 180, and the borderline is 180 and more 
than 180 and less than 320, and the abnormal 
range is 320 and more than 320. 
 
Ethical Considerations: 
    This study has been fundamentally performed 
in compliance with the ethical principles based on 
the Declaration of Helsinki. Moreover, the 
additional commentary was conducted on the 
Ethical Guidelines for Research in the medical 
field for Humans and in accordance with the 
Good Clinical Practice (GCP). They were found 
associated with the ongoing consideration for the 
protection of human rights. Further, ―Ethical 
Guidelines for Epidemiology Research‖ was 
applied as an adequate guideline. It was 
presented in Japan by the Ministry of Education, 
Culture, Sports, Science, and Technology and 
the Ministry of Health, Labor and Welfare. 
 
    The author and our researchers have 
established an ethical committee. As regard to 
the discussion for the medical and ethical 
problems, included professions were a medical 
doctor, nurse, pharmacist, nutritionist and other 
experts in the legal specialty. For the current 
investigation, our discussion resulted in 
appropriate and valid, with the agreements. 
From the point of patients’ view, the informed 
consents and written document agreements 
have been obtained from all the subjects. 
Current investigation has been registered by the 





    In the current study, 47 patients with T2DM 
were enrolled and their fundamental data of 
several biomarkers were shown in Table-1. 
Average ages in 4 groups were from 51.3 to 
65.3 years old, and the number of male/female 
was 20 / 27, respectively. The grouping was 
performed by the level of average blood 
glucose, which were 124mg/dL, 160mg/dL, 
206mg/dL, 281mg/dL, respectively.  HbA1c 
value in 4 groups was 6.1, 7.1, 8.0 and 8.9%, 
respectively. 
 
    The average blood glucose 2 hours after 
breakfast on day 2 vs day 4 in 4 groups were as 
follows: 141.6 vs 116.6 mg/dL, 194.8 vs 151.2 
mg/dL, 271.3 vs 181.8 mg/dL and 323.0 vs 
226.0 mg/dL, respectively.  
 
    The median value of the immunoreactivity of 
insulin (IRI) on fasting in each group was 6.7, 
7.5, 4.1 and 5.6μU/mL respectively. The value 
of HOMA-β in each group was 76.5, 29.3, 21.3 
and 11.8, respectively. The median value of 
triglyceride on fasting on day 2 vs day 14 in 4 
groups were as follows: 120 vs 73 mg/dL, 107 









Manuscript no: ASJBCCR-2-S1-002 Volume: 2     Special Issue: 1   8 
Short name: ASJBCCR 
 
 Special Issue: Original Article Low Carbohydrate Diet 
Citation: Bando H, Ebe K, Muneta T, et al., “Difference of Glucose variability between Low Carbohydrate 
Diet (LCD) and Calorie Restriction (CR)”. Asp Biomed Clin Case Rep, vol.2, no.s1: 4-15, 2019. 
Table-1:  Biomarkers in the subjects classified for 4 groups 
Group   Group 1 Group 2 Group 3 Group 4 
Subjects 
Number 12 12 12 11 
Sex (male/female) 6/6 3/9 6/6 5/6 
Age (years old.) 51.3 ± 13.1 60.9 ± 16.5 65.3 ± 8.7 60.6 ± 5.7 
Glucose  
HbA1c (%) 6.1 ± 0.9 7.1 ± 0.9 8.0 ± 1.0 8.9 ± 1.2 
Glucose (0) on day 2 
(mg/dL) 
109.2 ± 16.2 135.5 ± 18.1 177.7 ± 36.3 220.4 ± 29.5 
Glucose (120) on day 
2 (mg/dL) 
141.4 ± 32.0 194.8 ± 34.9 271.3 ± 36.5 323.0 ± 45.0 
Glucose (0) on day 4 
(mg/dL) 
 91.7 ± 15.4 122.1 ± 14.3 142.2 ± 19.3 177.6 ± 22.0 
Glucose (120) on day 
4 (mg/dL) 
116.6 ± 15.4 151.2 ± 15.3 181.8 ± 17.6 226.0 ± 29.4 
Resistance 
Insulin (0) on day 2 
(μU/mL) 
6.7 [2.6 - 11.7] 7.5 [3.9 - 9.5] 4.1 [3.5 - 9.0] 
5.6 [3.3 -
7.3] 
HOMA-R 2.2 [0.7 - 3.3] 2.3 [1.2 - 3.3] 2.1 [1.2 - 3.9] 
3,0 [1.9 - 
4.3] 
HOMA-β 
76.5 [24.1 - 
83.1] 
29.3 [ 19.7 - 
50.3] 
21.3 [ 10.2 - 
29.7] 
11.8 [7.6 - 
16.6] 
Lipids 
Triglyceride on day 2 
(mg/dL) 
120 [69 - 155] 
107 [ 77 - 
126] 
116 [77 - 
134] 
190 [169 - 
257] 
Triglyceride on day 14 
(mg/dL) 
73 [57 - 103] 86 [ 75 - 94] 85 [58 - 107] 
124 [95 - 
152] 
HDL-Chol on day 2 
(mg/dL) 
57 [51 - 75] 50 [ 47 - 67] 74 [ 65 - 78] 60 [44 - 73] 
HDL-Chol on day 14 
(mg/dL) 
48 [44 - 61] 47 [ 43 - 64] 60 [46 - 74] 46 [ 41 - 65] 
LDL-Chol on day 2 
(mg/dL) 
120 [106 - 147] 
115 [ 84 - 
134] 
151 [112 - 
164] 
155 [141 - 
186] 
LDL-Chol on day 14 
(mg/dL) 
133 [113 - 153] 
136 [ 118 - 
165] 
136 [122 - 
152] 
179 [142 - 
199] 
The results were expressed by mean ± SD or median [25% - 75%]. 
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Daily profile of blood glucose: 
 
   Daily profile of blood glucose in 4 groups was investigated (Fig-1). Blood glucose variability in 4 
groups showed the parallel pattern. Among them, blood glucose value is the lowest in group 1 and is 
the highest in group 4. Acute elevation of blood glucose was observed from 0800h to 1000h on the 

























HbA1c and M value: 
    Comparison of HbA1c and M value in 4 groups are shown in Fig-2. The median value of HbA1c 





















Fig- 2: Comparison of HbA1c and M value in 4 groups 
Fig- 2a: HbA1c value was increased from group 1 to 4   Fig- 2b: M values was increased from group 1 to 4. 
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    Regarding median values in groups 1 to 4, a linear increase was observed in HbA1c and a sharp 
increase in M value which is like a quadratic curve. 
 
HOMA-R and HOMA-β: 
    Comparison of   HOMA-R and  HOMA-β  in 4  groups  is  shown  in  Fig-3. The median  value   of  
HOMA-R  did  not show the difference  in 4 groups (Fig-3a). In contrast, the median value of HOMA-β 






















Changes in average blood glucose: 
    Changes in average blood glucose from day 2 to day 4 in 4 groups were shown in Fig-4. Subjects 
have CR meal on day 1 and 2, and LCD meal on day 3-14. In group 1-4, the median value of daily 





Fig- 3: Comparison of HOMA-R and HOMA-β in 4 groups 
Fig-3a: The median value of HOMA-R did not                Fig- 3b: The median value of HOMA-β decreased  
 show difference in 4 groups.                                           from group 1 to 4. 
 
 
 Fig- 4: Changes in average blood glucose from day 2 to day 4 in 4 groups 
    Subjects have CR meal on day 1 and 2 and LCD on day 3-14. In group 1-4. The median value of daily        
blood glucose in average decreased from day 2 to day 4. 
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Comparison on day 2 vs day 4: 
The levels of M value on day 2 vs day 4 were compared in 4 groups (Fig-5). The median value in 
each group was 7.1 vs 10.5, 39.7 vs 5.0, 139 vs 15.7, 367 vs88, respectively. In group 1, the data of 

















Correlation among biomarkers: 
Correlations of biomarkers among HbA1c, M value, and average blood glucose were shown in Fig-
6. There are significant correlations between HbA1c and average blood glucose on day 2 (p<0.01), 
















Correlation between day 2 and 4: 
    Correlations of the value of day 2 and day 4 in M value and in average blood glucose were shown 
in Fig-7. There are significant correlations between the value of 2 and day 4 in average blood glucose 




Fig 5: Changes in M value from day 2 to day 4 in 4 groups 
    Subjects have CR meal on day 1 and 2 and LCD on day 3-14. In group 1-4. M value decreased in 4 groups 













Fig- 6: Correlations of biomarkers HbA1c, M value and average blood glucose. 
   There are significant correlations between HbA1c and average blood glucose on day 2 (p<0.01), and between 
HbA1c and M value on day 2 (p<0.01). 
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     Regarding nutritional therapy for diabetes 
mellitus, clinical research for CR and LCD have 
been found for years [11,14,23]. For the 
development of LCD medically and socially, 
three types of LCD meals have been presented. 
They are super LCD, standard LCD, and petite 
LCD, which are including carbohydrate as the 
ratio of 12%, 26% and 40%, respectively 
[12,14]. Actually, the type of LCD used in this 
study was super-LCD, which has evaluated as 
an effective LCD meal for obesity and diabetes 
[24, 25]. 
 
    In the current study, glycemic variability on 
CR and LCD were measured and investigated. 
As to our protocol, we have had experiences of 
clinical research using CR meal and LCD meal 
[26]. By combined data of daily profile of blood 
glucose, HbA1c, M value, a pathophysiological 
aspect of precise glucose variability would be 
clarified. The results of this study are obtained in 
Figures, which will be discussed in this order.  
 
    The attributes of the subjects in the 4 groups 
were not remarkably different. As a result of 
categorizing to 4 groups with mean blood 
glucose, the mean HbA1c and median M value 
seemed to be reasonable. On day 2 and 14, the 
TG value was remarkably decreased, which was 
the same tendency as previously reported 
[25,27]. On the other hand, there were no 
obvious changes in HDL and LDL. 
 
    Meals administered to the subjects were CR 
on days 1-2 and LCD on days 3-14. Only 24 
hours after changing to LCD, glucose profile on 
day 4 was studied. Pre-prandial blood glucose 
levels on 0800h, 1200h and 1700h were 
decreased dramatically on day 4 in comparison 
with those on day 2. Furthermore, postprandial 
blood glucose elevation on 1000h, 1400h, and 
1900h was remarkably suppressed. 
Consequently, these changes seem to be 
clinically obvious effects of LCD. 
 
    The median values of HbA1c and M value 
increased similarly for groups 1 to 4. As to 
HbA1c, the overlapping area in each group was 
broad, whereas in M value there were few 
overlapping regions and the distribution was 
rather distant from each other. This is one of the 
characteristic features of M value [28]. When the 
level of blood glucose and MAGE become 
higher, the M value will increase remarkably. 
Therefore, M value seems to be clinically useful 
when we evaluate the glycemic variability. In 
other words, we can compare the difference 
between the diabetic cases, and also the 
difference of clinical course for a certain diabetic 
patient. 
 
    HOMA is an index calculated from the ratio of 
blood glucose level and insulin value [29]. There 
are two biomarkers, in which HOMA-R is related 
to insulin resistance and HOMA-β is deeply 
related to insulin secretion ability [30]. From the 












Fig- 7: Correlations of the value of day 2 and day 4 in M value and in average blood glucose. 
   There are significant correlations between the value of day 2 and day 4 in average blood glucose (p<0.01), and 
in M value. 
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may be a decrease in insulin secretion ability for 
groups 1 to 4. 
 
As to 4 groups, when comparing the average 
blood glucose on day 2 and 4, the apparent 
decrease was observed for 24 hours. The extent 
of the decrease was found small to larger in the 
order of the group 1 to 4. In particular, group 4 
showed a remarkable decrease in median 
average blood glucose level from 277 mg / dL to 
201 mg / dL for 48 hours apart. As described 
above, LCD has clinically a hypoglycemic effect. 
As the initial blood glucose level is higher, there 
seems to be a tendency with larger decreasing 
effect. 
 
For comparison of day 2 vs day 4, mean blood 
glucose remarkably decreased in group 1-4. 
However, M value in group 1 did not show a 
decline. The reason would be that the M value 
becomes the minimum level when the blood 
glucose is around 120 mg/dL, indicating almost 
zero [31]. Therefore, the mean blood glucose level 
decreased in group 1, while the M value did not 
show a decrease. On the other hand, M value in 
group 3,4 decreased remarkably on day 4 than 
that of day 2. Compared to the decrease in mean 
blood glucose, the decrease of M value seems to 
be very to large extent. This is a beneficial point of 
M value, indicating both the mean blood sugar 
and mean amplitude of glycemic excursions 
(MAGE) [32]. Thus, M value would be useful in the 
comparative study. 
 
There was a significant correlation between 
HbA1c and mean blood glucose on day 2, with a 
high correlation coefficient as R
2
 = 0.55. The 
obtained formula was y = 0.0172 x + 4.2087. 
Meanwhile, the standard formula reported by 
Nathan et al. has been known, which is average 
blood glucose level (mg / dL) = 28.7 x A1 c (%) - 
46.7 [33]. 
 
    Here, both formulas would be compared and 
calculated. For example, 3 cases are tried where 
the average blood glucose is 120 mg/dL, 150 
mg/dL, 180 mg/dL. Our formula showed HbA1c = 
6.2%, 6.8%, 7.3%, respectively, and Nathan's 
formula showed HbA1c = 5.8%, 6.8%, 7.8%, 
respectively. Both indicated the same value of 
HbA1c when the blood glucose is 150 mg/dL. 
Regarding the inclination of the HbA1c change, 
it is smaller in our equation and larger in 
Nathan's equation. 
     
     One reason would be the difference in the 
subjects. Our study covers 47 T2DM patients 
with a rather limited study. In contrast, Nathan 
et al. included thousands of normal individuals, 
diabetic patients with mild to severe range of 
subjects. It is inferred that the differences would 
be from this distribution difference in both.  
 
There were significant correlations between 
HbA1c and M value on day 2 (p<0.01). The 
correlated pattern was not linear, but 
logarithmic distribution. Its characteristic points 
were rather different in each level as follows: i) 
M value is rather low when HbA1c is about 5.0 
– 7.0 %, ii) it increases abruptly when HbA1c is 
7.0% - 8.0 %, iii) it is widely distributed when 
HbA1c is more than 8.0% [34]. From these 
findings, diabetic cases with HbA1c value of 
more than 8.0% probably show wider glucose 
variability with average glucose and MAGE. 
 
The average blood glucose between Day 2 
and Day 4 showed a high correlation coefficient 
with R
2
 = 0.85. The equation was y = 0.58 x + 
34.0, and we can speculate the average blood 
glucose of day 4 from the data on day 2. If the 
average blood glucose is 270 mg/dl on day 2, 
the estimated value on day 4 is 191 mg/dL. If it 
is 180mg/dL on day 2, it would 138 mg/dL on 
day 4. Thus, the clinical effect of LCD can 
develop research possibility [25, 35]. 
 
Moreover, there was significant correlation of 
M value between Day 2 and Day 4 (p<0.01), 
with the equation as y = 0.21 x + 0.16, and R
2
 = 
0.73. It showed the rapid decrease of M value 
for only 2 days. This may be due to a sharp 
improvement in MAGE as well as decreased 
mean blood glucose. As described above, this 
effect is found only two days after the meal 
change from CR to LCD. Thus, the efficacy of 
LCD would be clinically remarkable in the light 
of glucose variability. 
 
Manuscript no: ASJBCCR-2-S1-002 Volume: 2     Special Issue: 1  14 
Short name: ASJBCCR 
 
 Special Issue: Original Article Low Carbohydrate Diet 
Citation: Bando H, Ebe K, Muneta T, et al., “Difference of Glucose variability between Low Carbohydrate 
Diet (LCD) and Calorie Restriction (CR)”. Asp Biomed Clin Case Rep, vol.2, no.s1: 4-15, 2019. 
Conclusion 
    In summary, 47 patients with T2DM were 
studied in the current report. We investigated 
diabetes-related biomarkers such as HbA1c, 
blood glucose, IRI, HOMA-R, HOMA-β, M value 
and lipids, and mutual correlations among them. 
Daily blood glucose on LCD showed decreased 
level compared with that of CR. Several 
significant correlations were found among 
diabetes-related biomarkers. These results 
suggest that LCD would be an effective 
nutritional therapy for improving glucose 
variability and that obtained findings would 
become a basal reference for future research 
development in this field. 
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